ROMA Index | When was the last time you were tested?

The ROMA index, or ovarian malignancy risk assessment algorithm, combines carcinoembryonic antigen (Ca-125) and human epididymal protein 4 (HE4) and assesses menopausal status and risk of ovarian malignancy in women with small pelvic masses.

"Synevo" offers a ROMA-index survey, which can be booked both on-site and online.




Carry out a laboratory study and take advantage of a discount on the online consultation of an onco-surgeon-mammologist!






👁Follow our social pages and learn more

Call Now Button